Showing results (61-70 of 4,632) with videos related to
Sort By:
Pageof 464
Blood|May 1, 1996
Specific human cellular immunity to bcr-abl oncogene-derived peptidesM Bocchia, T Korontsvit, Q Xu, et al.The Journal of Experimental Medicine|October 1, 1992
Engineered humanized dimeric forms of IgG are more effective antibodiesP C Caron, W Laird, M S Co, et al.Blood|May 15, 1995
Specific binding of leukemia oncogene fusion protein peptides to HLA class I moleculesM Bocchia, P A Wentworth, S Southwood, et al.International Journal of Peptide and Protein Research|September 1, 1994
Amino acid sequence and properties of vasopressin-associated elephant neurophysinH B Huang, D Wellner, R Naudé, et al.Cancer Research|December 15, 1992
Biological and immunological features of humanized M195 (anti-CD33) monoclonal antibodiesP C Caron, M S Co, M K Bull, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 24, 2001
Parametric images of antibody pharmacokinetics in Bi213-HuM195 therapy of leukemiaK S Kolbert, K A Hamacher, J G Jurcic, et al.Blood|April 15, 1991
Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid-specific monoclonal antibodies and drugs in combinationR M Lemoli, C Gasparetto, D A Scheinberg, et al.Blood|October 25, 2001
Prognostic significance of minimal residual disease detection and PML/RAR-alpha isoform type: long-term follow-up in acute promyelocytic leukemiaJ G Jurcic, S D Nimer, D A Scheinberg, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1992
Chimeric and humanized antibodies with specificity for the CD33 antigenM S Co, N M Avdalovic, P C Caron, et al.Biochemical and Biophysical Research Communications|January 13, 1997
Biochemical evidence for orphanin FQ/nociceptin receptor heterogeneity in mouse brainJ P Mathis, J Ryan-Moro, A Chang, et al.Pageof 464